Simulations Plus SLP Commercialization — Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Simulations Plus in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Simulations Plus’s 10-Q, filed April 10, 2026, on SEC EDGAR. View the filing →
Ask your AI about Simulations Plus's commercialization — revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Simulations Plus's commercialization — revenue?
- Simulations Plus (SLP) reported commercialization — revenue of $2.28M in Q4 2025.
- What does commercialization — revenue mean?
- This metric represents the total revenue generated from the commercialization segment, which encompasses the sale of software products and associated consulting services for pharmaceutical research. It serves as a key indicator of the company's ability to monetize its intellectual property and research tools within the life sciences market. Tracking this revenue stream helps investors assess the growth trajectory and market adoption of the company's core software offerings.